Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+/HER2− breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score

2026/07/14 by Zohre Sadeghian, Sara Rhode, Hadi Sultan +5
Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #HER2/EGFR in Cancer Research #Advanced Breast Cancer Therapies

paper · doi:10.1016/j.humpath.2026.106214

Citations

• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer